Olasiman, Rebecca D.
HRN: 26-05-18 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2024
CEFTRIAXONE 1G (VIAL)
10/19/2024
10/25/2024
IV
2g
OD
Pneumonia
Waiting Final Action